Gabriele Sass

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Health Risk Assessment

Pseudomonas Aeruginosa

Stem Cell Transplantation

Top Venues

Antimicrobial agents and chemotherapy

California Institute for Medical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

California Institute for Medical Research Dec 1o 2015

United States

Senior Scientist :: Infectious Diseases

Publications

Gabriele Sass, David J Larwood, David A Stevens
Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans. Mycopathologia (2023)
Gabriele Sass, David J Larwood, Marife Martinez, David A Stevens
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates. Mycoses (2023)
Gabriele Sass, David J Larwood, Marife Martinez, David A Stevens
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates. Mycoses (2023)
Gabriele Sass, David J Larwood, Marife Martinez, Paulami Chatterjee, Melissa O Xavier, David A Stevens
Nikkomycin Z against Disseminated Coccidioidomycosis in a Murine Model of Sustained-Release Dosing. Antimicrobial agents and chemotherapy 65 (10) (2021)
Gabriele Sass, Shajia R Ansari, Anna-Maria Dietl, Éric Déziel, Hubertus Haas, David A Stevens
Intermicrobial interaction: Aspergillus fumigatus siderophores protect against competition by Pseudomonas aeruginosa. PloS one 14 (5) (2019)
Patrick R Secor, Gabriele Sass, Hasan Nazik, David A Stevens
Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosa. PloS one 12 (6) (2017)